Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1983
Upper half body irradiation (UHBI) for extensive small cell carcinoma of the lung
D G Payne, L Yeoh, R Feld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1993
A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study
S Verma, I C Quirt, E A Eisenhauer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1986
Ewing's sarcoma: a trial of adjuvant chemotherapy and sequential half-body irradiation
M P Berry, R D Jenkin, A R Harwood, et al.
Hematology (Amsterdam, Netherlands)
|
June 16, 2001
Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice
J. E. Curtis, Y. Hao, H. A. Messner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1984
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung
R Feld, W K Evans, G DeBoer, et al.
Archives of Internal Medicine
|
March 1, 1981
Combined modality treatment of small cell carcinoma of the lung
R Feld, J F Pringle, W K Evans, et al.
Cancer
|
November 1, 1987
Neurologic disorders in patients with small cell lung cancer
J P Sculier, R Feld, W K Evans, et al.
Cancer
|
February 15, 1986
Superior vena caval obstruction syndrome in small cell lung cancer
J P Sculier, W K Evans, R Feld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group
I C Quirt, W E Shelley, J L Pater, et al.
The New England Journal of Medicine
|
December 9, 1993
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma
R M Meyer, I C Quirt, J R Skillings, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1983
Upper half body irradiation (UHBI) for extensive small cell carcinoma of the lung
D G Payne, L Yeoh, R Feld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1993
A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study
S Verma, I C Quirt, E A Eisenhauer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1986
Ewing's sarcoma: a trial of adjuvant chemotherapy and sequential half-body irradiation
M P Berry, R D Jenkin, A R Harwood, et al.
Hematology (Amsterdam, Netherlands)
|
June 16, 2001
Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice
J. E. Curtis, Y. Hao, H. A. Messner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1984
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung
R Feld, W K Evans, G DeBoer, et al.
Archives of Internal Medicine
|
March 1, 1981
Combined modality treatment of small cell carcinoma of the lung
R Feld, J F Pringle, W K Evans, et al.
Cancer
|
November 1, 1987
Neurologic disorders in patients with small cell lung cancer
J P Sculier, R Feld, W K Evans, et al.
Cancer
|
February 15, 1986
Superior vena caval obstruction syndrome in small cell lung cancer
J P Sculier, W K Evans, R Feld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group
I C Quirt, W E Shelley, J L Pater, et al.
The New England Journal of Medicine
|
December 9, 1993
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma
R M Meyer, I C Quirt, J R Skillings, et al.
Page
of 3